Cancer Immunology: Not So Secret Anymore
-- Scientists and prostate cancer patients alike cheered when the FDA approved Provenge, the first therapeutic vaccine for prostate cancer, in April 2010. A few months later, a second group of researchers published a clinical study that suggested the…